Wegovy has been indicated by the FDA to treat obesity, however, close monitoring is required
Whats more, price differentials between countries, supply shortages, heavy cost-bearing for payers and legal scrutiny call for something to give
Novo Nordisk reacts to Mark Cuban TheStreet explained Cubans comments to a spokesperson for Novo Nordisk, who offered the following response: Novo Nordisk continuously explores innovative ways to make our products available and accessible to more patients, wrote Allison Schneider, Novo Nordisks director of media relations and issues management
If you maintain a healthy weight and a healthy lifestyle, you should enjoy your new flat abdomen for the duration
Ozempic is the diabetes version of the same molecule, often used off-label for weight loss because it is cheaper and more available but this contributed to the global shortage that harmed diabetic patients
retatrutide has Phase 3 data but no regulatory submission yet